Skip to content

Sabra Healthcare SBRA Q4 2024 Annual earnings

Reported February 19, 2025 · After market close

Revenue$182.3MBeat by $4.3M
EPS$0.36In line
Revenue estimate$178.0M
EPS estimate$0.36

Next report

Aug 3, 2026 (In 5 days)
Revenue estimate$219.4M
EPS estimate$0.17

Financials

Q4 2024

Income statement

See full
Revenue$182.3M+11.6%
Net income$46.7M+172%
EPS (diluted)$0.20+186%

Balance sheet

See full
Cash & equivalents$60.5M+46.5%
Total debt$8.3M-33.6%
Total equity$2.7B-2.2%
Total assets$5.3B-1.5%

Cash flow

See full
Operating cash flow$80.0M+1.6%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$4.1B+24.2%
Enterprise value$4.05B+23.7%
P/E32.3×-208×
P/S5.8×+0.7×

Profitability

See full
Net margin18%+15.9pp

Returns & leverage

See full
Return on equity4.6%+4.1pp
Debt / equity0.0×

Versus estimates

Ask the moment Sabra Healthcare reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Sabra Healthcare report Q4 2024 earnings?
Sabra Healthcare (SBRA) reported Q4 2024 earnings on February 19, 2025 after market close.
What were Sabra Healthcare's Q4 2024 revenue and EPS?
Sabra Healthcare reported revenue of $182.3M and eps of $0.36 for Q4 2024.
Did Sabra Healthcare beat estimates in Q4 2024?
Revenue beat the consensus estimate of $178.0M by $4.3M. EPS beat the consensus estimate of $0.36 by $0.00.
Where can I find Sabra Healthcare's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001492298-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.